Our Partners
[lsp_slider slider=our_partners]
[tdc_zone type=”tdc_content”]
Wipro GE Healthcare is keen to invest in technologies that are affordable to all.
Terri Bresenhem, President and Chief Executive, GE Healthcare, told reporters here on Wednesday that the company has not only been expanding its presence in India for over two decades now, but investing at least 30 per cent more in recent years. “The investment is both in terms of manpower and strengthening our research and development facility,” she said.
INDIA MANUFACTURE
“We are striving to make healthcare affordable to all. While most medical equipment companies that have established their presence here import close to 80 per cent of their equipment, our import component is less. At GE Healthcare, we design and manufacture 30 per cent of the equipment in India. We have a strong research team, high quality thinkers and innovators here,” she added.
Receive USD 4 Million Award from The Wellcome Trust for Development and Clinical Trials Hyderabad, India, June 18, 2012: Bharat Biotech and The University of Maryland Center for Vaccine Development (“CVD”) announced today a significant milestone achievement– receiving a USD 4 Million Strategic Translation Award from The Wellcome Trust for clinical development of a new conjugate vaccine including initial clinical trials beginning in three years to prevent the potentially lethal infectious disease caused by invasive non-typhoidal Salmonella (NTS). NTS have emerged as an important cause of invasive bloodstream infection in sub-Saharan Africa, among young children with malaria and malnutrition, and among adults with HIV. Strains of nontyphoidal Salmonella (“NTS”) that can cause systemic disease such as meningitis or sepsis are particularly common in sub-Saharan Africa; approximately 20 to 30% of children with such invasive NTS infections die.
[lsp_slider slider=our_partners]